Healthpeak Properties (NYSE:DOC) Hits New 12-Month High on Analyst Upgrade

Healthpeak Properties, Inc. (NYSE:DOC)’s stock price hit a new 52-week high during trading on Thursday after Wells Fargo & Company raised their price target on the stock from $20.00 to $22.00. Wells Fargo & Company currently has an equal weight rating on the stock. Healthpeak Properties traded as high as $22.13 and last traded at $22.1050, with a volume of 342183 shares. The stock had previously closed at $21.74.

A number of other research analysts have also recently commented on DOC. Raymond James Financial assumed coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating on the stock. Evercore lowered Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective on the stock. in a research report on Monday, May 11th. Morgan Stanley reissued an “equal weight” rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. BMO Capital Markets upped their target price on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 15th. Finally, JPMorgan Chase & Co. increased their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Four investment analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. Based on data from MarketBeat, Healthpeak Properties currently has an average rating of “Hold” and a consensus target price of $20.62.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.23% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently modified their holdings of the stock. New York Life Investment Management LLC grew its position in shares of Healthpeak Properties by 65.8% in the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after buying an additional 61,952 shares during the last quarter. Northside Capital Management LLC lifted its stake in Healthpeak Properties by 47.7% in the fourth quarter. Northside Capital Management LLC now owns 472,337 shares of the real estate investment trust’s stock worth $7,595,000 after acquiring an additional 152,579 shares during the period. Oak Thistle LLC bought a new stake in Healthpeak Properties in the fourth quarter valued at $3,938,000. HF Advisory Group LLC bought a new stake in Healthpeak Properties in the fourth quarter valued at $1,517,000. Finally, Baillie Gifford & Co. boosted its holdings in Healthpeak Properties by 613.2% in the fourth quarter. Baillie Gifford & Co. now owns 367,256 shares of the real estate investment trust’s stock valued at $5,905,000 after acquiring an additional 315,763 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 1.8%

The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The firm has a market capitalization of $15.25 billion, a PE ratio of 69.20, a P/E/G ratio of 3.36 and a beta of 1.02. The stock’s 50-day simple moving average is $20.36 and its 200-day simple moving average is $18.17.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.5%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.